208 related articles for article (PubMed ID: 38300480)
1. Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma.
Gritsch D; Santagata S; Brastianos PK
Curr Treat Options Oncol; 2024 Feb; 25(2):261-273. PubMed ID: 38300480
[TBL] [Abstract][Full Text] [Related]
2. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract][Full Text] [Related]
3. Craniopharyngioma: a roadmap for scientific translation.
Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm.
Calvanese F; Jacquesson T; Manet R; Vasiljevic A; Lasolle H; Ducray F; Raverot G; Jouanneau E
Front Endocrinol (Lausanne); 2022; 13():882381. PubMed ID: 35757402
[TBL] [Abstract][Full Text] [Related]
5. Successful Use of BRAF/MEK Inhibitors as a Neoadjuvant Approach in the Definitive Treatment of Papillary Craniopharyngioma.
Khaddour K; Chicoine MR; Huang J; Dahiya S; Ansstas G
J Natl Compr Canc Netw; 2020 Dec; 18(12):1590-1595. PubMed ID: 33285519
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
[TBL] [Abstract][Full Text] [Related]
7. BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.
Brastianos PK; Twohy E; Geyer S; Gerstner ER; Kaufmann TJ; Tabrizi S; Kabat B; Thierauf J; Ruff MW; Bota DA; Reardon DA; Cohen AL; De La Fuente MI; Lesser GJ; Campian J; Agarwalla PK; Kumthekar P; Mann B; Vora S; Knopp M; Iafrate AJ; Curry WT; Cahill DP; Shih HA; Brown PD; Santagata S; Barker FG; Galanis E
N Engl J Med; 2023 Jul; 389(2):118-126. PubMed ID: 37437144
[TBL] [Abstract][Full Text] [Related]
8. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].
Fujio S; Hanaya R
No Shinkei Geka; 2023 Sep; 51(5):917-928. PubMed ID: 37743344
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
Brastianos PK; Taylor-Weiner A; Manley PE; Jones RT; Dias-Santagata D; Thorner AR; Lawrence MS; Rodriguez FJ; Bernardo LA; Schubert L; Sunkavalli A; Shillingford N; Calicchio ML; Lidov HG; Taha H; Martinez-Lage M; Santi M; Storm PB; Lee JY; Palmer JN; Adappa ND; Scott RM; Dunn IF; Laws ER; Stewart C; Ligon KL; Hoang MP; Van Hummelen P; Hahn WC; Louis DN; Resnick AC; Kieran MW; Getz G; Santagata S
Nat Genet; 2014 Feb; 46(2):161-5. PubMed ID: 24413733
[TBL] [Abstract][Full Text] [Related]
11. A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.
Fujio S; Juratli TA; Arita K; Hirano H; Nagano Y; Takajo T; Yoshimoto K; Bihun IV; Kaplan AB; Nayyar N; Fink AL; Bertalan MS; Tummala SS; Curry WT; Jones PS; Martinez-Lage M; Cahill DP; Barker FG; Brastianos PK
Neurosurgery; 2019 Aug; 85(2):204-210. PubMed ID: 30481321
[TBL] [Abstract][Full Text] [Related]
12. Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift.
Nussbaum PE; Nussbaum LA; Torok CM; Patel PD; Yesavage TA; Nussbaum ES
J Clin Pharm Ther; 2022 Jun; 47(6):826-831. PubMed ID: 35023192
[TBL] [Abstract][Full Text] [Related]
13. Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
Yue Q; Yu Y; Shi Z; Wang Y; Zhu W; Du Z; Yao Z; Chen L; Mao Y
J Neurosurg; 2018 Jul; 129(1):27-34. PubMed ID: 28984520
[TBL] [Abstract][Full Text] [Related]
14. Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature.
Borrill R; Cheesman E; Stivaros S; Kamaly-Asl ID; Gnanalingham K; Kilday JP
Childs Nerv Syst; 2019 Jan; 35(1):169-173. PubMed ID: 30069716
[TBL] [Abstract][Full Text] [Related]
15. Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review.
Yu N; Raslan OA; Lee HS; Theeler BJ; Raafat TA; Fragoso R; Shahlaie K; Aboud O
CNS Oncol; 2024 Jan; 13(1):CNS106. PubMed ID: 38348829
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Successful Use of BRAF/MEK Inhibitors in Aggressive BRAF-mutant Craniopharyngioma.
Wu ZP; Wang YL; Wang LC; Liu ZY; Fan RR; Zan X; Liang RC; Yang JL; Zhou LX; Xu JG
World Neurosurg; 2023 Dec; 180():e117-e126. PubMed ID: 37683921
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapy in the Management of Modern Craniopharyngiomas.
Reyes M; Taghvaei M; Yu S; Sathe A; Collopy S; Prashant GN; Evans JJ; Karsy M
Front Biosci (Landmark Ed); 2022 Apr; 27(4):136. PubMed ID: 35468695
[TBL] [Abstract][Full Text] [Related]
18. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
Robinson LC; Santagata S; Hankinson TC
Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
[TBL] [Abstract][Full Text] [Related]
19. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
20. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.
Agosti E; Zeppieri M; Antonietti S; Piazza A; Ius T; Fontanella MM; Fiorindi A; Panciani PP
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
